Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials ; day:23 ; month:2 ; year:2022 ; pages:1-11
Cancer immunology immunotherapy ; (23.2.2022), 1-11
- Urheber
-
Ormhøj, Maria
Abken, Hinrich
Hadrup, Sine R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-022-03163-y
- URN
-
urn:nbn:de:101:1-2022052522310881720179
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ormhøj, Maria
- Abken, Hinrich
- Hadrup, Sine R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
Chimeric antigen receptor T‑cell therapy—a hematological success story
Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Targeting Pim kinases in hematological cancers: molecular and clinical review
Therapeutic advances in the targeting of ROR1 in hematological cancers
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
The development of chimeric antigen receptor T-cells against CD70 for renal cell carcinoma treatment
Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers
The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
Chimeric antigen receptor T‑cell therapy—a hematological success story
Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Targeting Pim kinases in hematological cancers: molecular and clinical review
Therapeutic advances in the targeting of ROR1 in hematological cancers
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
The development of chimeric antigen receptor T-cells against CD70 for renal cell carcinoma treatment
Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers
The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
Chimeric antigen receptor T‑cell therapy—a hematological success story
Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Targeting Pim kinases in hematological cancers: molecular and clinical review
Therapeutic advances in the targeting of ROR1 in hematological cancers
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
The development of chimeric antigen receptor T-cells against CD70 for renal cell carcinoma treatment
Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers